Literature DB >> 2752166

Chronic immune thrombocytopenic purpura--immunological analyses of a patient pre- and post-HIV seroconversion.

P J Späth1, A Elisa, U Bühlmann, L Luginbühl, P Imbach.   

Abstract

A seven year follow-up of immune parameters is reported for a patient with chronic immune thrombocytopenic purpura (ITP) pre and post human immunodeficiency virus (HIV) seroconversion. Therapies such as intravenous IgG, prednisone, vincristine, or Ciclosporin A had no clear-cut beneficial effect on platelet counts. A long-term normalization of platelet counts was achieved by splenectomy. At splenectomy the patient was seropositive for HIV, most likely transmitted by blood products received half a year prior to laparatomy. Mean plasma levels of the second component of complement, C2, were half of the normal values prior to and within the lowest normal range post HIV seroconversion. Nevertheless, the T cell-dependent B cell response to HIV, which is dependent on the activation of C3 via the classical pathway of complement, was normal: Western blot analysis of total IgG and of IgG subclass responses to individual HIV antigens proved to be unimpaired.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752166     DOI: 10.1007/bf00320261

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Complement and humoral immune parameters in bone marrow transplant recipients: effects of intravenous immunoglobulin administration.

Authors:  P J Späth; C Baumgartner; A Gratwohl; J E Doran; A Elisa; P Bachmann; R Scherz; C Berger; A Morell; A Tichelli
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 2.  Molecular immunobiology of complement biosynthesis: a model of single-cell control of effector-inhibitor balance.

Authors:  D H Perlmutter; H R Colten
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

5.  Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

Authors:  P Imbach; H P Wagner; W Berchtold; G Gaedicke; A Hirt; P Joller; C Mueller-Eckhardt; B Müller; E Rossi; S Barandun
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

6.  An extended C1q-binding assay using lactoperoxidase- and chloramine-T-iodinated C1q. Immediate distinction between immune-aggregate-mediated and non-immune-aggregate-mediated C1q binding.

Authors:  P J Spaeth; A Corvetta; U E Nydegger; M Montroni; R Buetler
Journal:  Scand J Immunol       Date:  1983-10       Impact factor: 3.487

7.  The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes.

Authors:  A Erdei; F Melchers; T Schulz; M Dierich
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

8.  Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus.

Authors:  C G Jackson; H D Ochs; R J Wedgwood
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

9.  Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.

Authors:  S Pahwa; R Pahwa; C Saxinger; R C Gallo; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Immune thrombocytopenic purpura: autoimmune or immune complex disease?

Authors:  V Kiefel; P Spaeth; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

View more
  1 in total

1.  Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer.

Authors:  Jiang Yang; Tai Wang; Lina Zhao; Vinagolu K Rajasekhar; Suhasini Joshi; Chrysafis Andreou; Suchetan Pal; Hsiao-Ting Hsu; Hanwen Zhang; Ivan J Cohen; Ruimin Huang; Ronald C Hendrickson; Matthew M Miele; Wenbo Pei; Matthew B Brendel; John H Healey; Gabriela Chiosis; Moritz F Kircher
Journal:  Nat Biomed Eng       Date:  2020-07-13       Impact factor: 25.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.